Last reviewed · How we verify
NCT05080140
Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study
trial testing Ezetimibe 10mg in Hyperlipidemia; Mixed in 3 participants. Status unknown.
1 July 2021
Quick facts
| Lead sponsor | Misr University for Science and Technology |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 3 |
| Start date | 1 June 2019 |
| Primary completion | 1 July 2021 |
| Estimated completion | 20 March 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Ezetimibe 10mg — full drug profile →
Conditions studied
- Hyperlipidemia; Mixed — all drugs for Hyperlipidemia; Mixed →
Sponsor
Misr University for Science and Technology
Who can join
Adults 18 to 70, any sex, with Hyperlipidemia; Mixed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled pharmacokinetic based study will be carried out on patients with both sexes and various ages, plasma triglycerides levels, clinical health disorders and using different agents for treatment of their hyperlipidemia in order to access the optimal drug therapy with best cost effectiveness in the elderly cases under investigation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05080140
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ezetimibe 10mg
Trials testing the same drug.
- NCT06547359 — A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects · Phase 1 · completed
- NCT05795517 — Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） · Phase 2 · completed
- NCT05661552 — Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI · Phase 4 · completed
- NCT05970679 — Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A · Phase 3 · completed
- NCT05613400 — Statin and Bone Health · Phase 4 · unknown
Other Misr University for Science and Technology trials
Trials by the same sponsor.
- NCT07472192 — Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With PDRN Versus Fractional · Phase 2 · recruiting
- NCT06782087 — A Comparative Study Between the Efficacy of Diode Laser and Nano-chitosan Gel on Activation of Non-vital in- Office Blea · Phase 1 · enrolling by invitation
- NCT07028957 — Effectiveness of Low Volume Versus High Volume of Local Anesthetic in Ultrasound Guided Combined Supraclavicular and Int · NA · active not recruiting
- NCT07000058 — Wide-Awake Local Anesthesia No Tourniquet (WALANT) With Versus Without Hyaluronidase for Hand Surgery · Phase 2, PHASE3 · active not recruiting
- NCT06999993 — Efficacy and Safety of Sodium Hyaluronate Gel Combined With Sodium Bicarbonate Versus Sodium Bicarbonate Alone in Preven · Phase 2, PHASE3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05080140 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Misr University for Science and Technology
- Last refreshed: 15 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05080140.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing